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Review
Methylmercury (MeHg) from natural or 
anthropogenic sources biomagnifies through 
the food chain and gives rise to human 
exposure primarily through consumption of 
higher trophic level fish and marine mammals 
[National Research Council (NRC) 2000]. 
MeHg crosses the placenta and readily 
passes through the blood–brain barrier, with 
even higher MeHg levels in fetal than in 
maternal circulation (Stern and Smith 2003). 
Vulnerability of the developing fetus to MeHg 
exposure was exemplified in Minamata, Japan, 
when pregnant women consumed seafood 
highly contaminated with MeHg. This 
resulted in extreme fetal abnormalities and 
neurotoxicity (i.e., microcephaly, blindness, 
severe mental and physical developmental 
retardation) even among infants born to 
mothers with minimal symptoms (Harada 
1995).
More subtle neurodevelopmental effects 
have been observed in populations with 
moderate MeHg exposures from regular 
consumption of fish and/or marine mammals, 
including associations of MeHg biomarkers at 
birth with decrements in memory, attention, 
language, and visual-motor skills in childhood 
(NRC 2000). Most recently, a growing 
body of literature has explored the impact 
of even lower levels of MeHg on a variety of 
health outcomes in both adults and children. 
Findings include potential adverse effects 
on fetal growth, neorulogic function, the 
cardiovascular system, and immune function.
Given that fish is a key source of dietary 
protein in much of the world, MeHg 
contamination of fish has the potential 
to impact the health of geographically 
diverse populations. Furthermore, fish is 
an important source of beneficial nutrients 
such as  polyunsaturated fat ty  ac ids 
(PUFA), iodine, selenium, and vitamin D. 
Development of dietary recommendations 
that balance nutritional benefits of fish with 
the contaminant risk has been a challenge for 
government regulatory agencies and public 
health professionals (Teisl et al. 2011). In this 
context, characterization of MeHg health risks 
is critical for the development of optimal fish 
consumption guidelines (Cohen et al. 2005a; 
Shimshack and Ward 2010). However, there 
has been limited, if any, synthesis of the 
available literature on the health effects of 
low-level MeHg exposure, despite its global 
relevance.
To synthesize the current state of knowl-
edge on the human health effects of low-level 
MeHg exposure, we focused on the epide-
miologic literature of mercury concentrations 
measured in biologic tissue. We examined 
the following questions: a) What are the key 
health effects of lower, prevalent levels of 
MeHg exposure in the general population, 
and what are the strengths and limitations 
of recent evidence regarding those health 
effects? b) What are potential confounders or 
modifiers of human health risks (synergistic or 
antagonistic) at low-level exposure? c) What 
important gaps exist in the current literature? 
The ultimate goal of this review was to provide 
a basis for optimizing future research efforts, 
as well as risk–benefit assessment and exposure 
remediation policies, worldwide.
Biomarkers of MeHg Exposure
Biomarkers of MeHg exposure, such as total 
mercury levels in hair or blood, are regarded 
as more accurate measures of human expo-
sure than dietary assessment (i.e., of fish con-
sumption) because MeHg concentrations 
vary both between and within fish species and 
because recall of specific species may be impre-
cise (Groth 2010). Although it is correlated 
with maternal hair, cord blood mercury may 
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Background: Methylmercury (MeHg) is a known neurotoxicant. Emerging evidence indicates it 
may have adverse effects on the neurologic and other body systems at common low levels of exposure. 
Impacts of MeHg exposure could vary by individual susceptibility or be confounded by beneficial 
nutrients in fish containing MeHg. Despite its global relevance, synthesis of the available literature 
on low-level MeHg exposure has been limited.
oBjectives: We undertook a synthesis of the current knowledge on the human health effects of 
low-level MeHg exposure to provide a basis for future research efforts, risk assessment, and exposure 
remediation policies worldwide. 
data sources and extraction: We reviewed the published literature for original human 
epidemiologic research articles that reported a direct biomarker of mercury exposure. To focus on 
high-quality studies and those specifically on low mercury exposure, we excluded case series, as 
well as studies of populations with unusually high fish consumption (e.g., the Seychelles), marine 
mammal consumption (e.g., the Faroe Islands, circumpolar, and other indigenous populations), or 
consumption of highly contaminated fish (e.g., gold-mining regions in the Amazon).
data synthesis: Recent evidence raises the possibility of effects of low-level MeHg exposure on 
fetal growth among susceptible subgroups and on infant growth in the first 2 years of life. Low-level 
effects of MeHg on neurologic outcomes may differ by age, sex, and timing of exposure. No clear 
pattern has been observed for cardiovascular disease (CVD) risk across populations or for specific 
CVD end points. For the few studies evaluating immunologic effects associated with MeHg, results 
have been inconsistent.
conclusions: Studies targeted at identifying potential mechanisms of low-level MeHg effects 
and characterizing individual susceptibility, sexual dimorphism, and nonlinearity in dose response 
would help guide future prevention, policy, and regulatory efforts surrounding MeHg exposure.
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better reflect fetal exposure than maternal hair 
(Grandjean et al. 2002). Mercury is excreted 
in breast milk, but it is not typically used as a 
matrix for assessing exposure, primarily because 
of low concentrations and variability in the 
proportion present as MeHg (Björnberg et al. 
2005; García-Esquinas et al. 2011; Miklavcic 
et al. 2011). Meconium and other tissues, such 
as umbilical cord, placenta, and nail tissue, 
although potentially useful, have not been used 
widely in epidemiologic studies (Gundacker 
et al. 2010; Rees et al. 2007). Urinary mercury 
reflects inorganic mercury levels and thus is 
not used as an indicator of MeHg exposure; 
however, in hair, nails, and blood, MeHg is 
the primary contributor to total mercury levels 
(Grandjean et al. 2002). 
Even the best exposure biomarkers are 
imprecise measures of MeHg in target organs 
such as the fetal brain. Furthermore, the aver-
age coefficient of variation is about 25% for 
cord blood mercury analysis and about twice 
that for maternal hair mercury (Grandjean and 
Budtz-Jørgensen 2010). Typically, imprecision 
in an exposure measure will attenuate its calcu-
lated effect (Rothman and Greenland 1998); 
this highlights the potential for measurement 
errors in MeHg exposure assessment to affect 
comparability of findings across studies. 
Low-Level Exposure
Because most of the published epidemiologic 
literature reports measures of total mercury 
rather than MeHg, we focused principally 
on studies with mercury exposure measures 
in blood or hair as matrices most reflective of 
MeHg. We excluded case reports or case series 
and reports that were not original research. We 
further limited our review to studies of low-
dose mercury exposures, that is, we excluded 
analyses of the poisoning episodes in Japan 
and Iraq, as well as studies of populations 
with mean measured mercury levels above 
any of the following: 4 μg/g in hair; 20 μg/L 
in cord blood, or approximately 12 μg/L 
in adult blood. We based our definition of 
low dose on a qualitative assessment of the 
literature and appreciation that findings from 
the three major cohort studies with moderate 
mercury exposures (the Faroe Islands, the 
Seychelles, and New Zealand) are already 
extensively reviewed (e.g., Axelrad et al. 2007; 
Cohen et al. 2005b; Rice 2004). Among the 
major prospective cohort studies of MeHg 
and child development in high exposure risk 
populations, the Faroes had the lowest mercury 
levels with approximately 4 μg/g in maternal 
hair and 20 μg/L in cord blood, on average 
(Steuerwald et al. 2000). We assumed a factor 
of 1.7 (Stern and Smith 2003) in estimating 
the corresponding adult blood mercury level of 
12 μg/L. By design, our definition of low dose 
excludes studies focused on moderately MeHg-
exposed groups, such as those with particularly 
high fish consumption (e.g., the Seychelles 
Islands), marine mammal consumption (e.g., 
the Faroe Islands and most circumpolar and 
other indigenous populations), or unusually 
contaminated fish consumption (e.g., gold-
mining regions of the Amazon).
Study Selection
Our review encompasses human epidemiologic 
studies that measured mercury using a bio-
marker. For example, in prenatal or childhood 
MeHg exposure assessment, studies measure 
primarily total mercury in whole blood (mater-
nal, umbilical cord, or child) or hair (maternal, 
infant, or child). For adult exposure, MeHg 
levels are typically estimated using total mer-
cury levels in whole blood, hair, or toenails. We 
included cohort studies irrespective of sample 
size and geographic location. To identify rel-
evant studies, we performed a literature search 
for studies that analyzed the relation between 
mercury exposure and health outcomes using 
PubMed (National Library of Medicine 2012) 
and ScienceDirect (Elsevier 2012). 
Birth Outcomes and Infant 
Growth
In searching the published literature on birth 
outcomes and infant growth, we used the fol-
lowing key words: “mercury,” “infant,” “fetus,” 
“birth outcome,” “biomarker,” “anthropomet-
ric,” “maternal,” “mother,” “child,” birth,” 
“pregnancy,” “blood,” “cord blood,” “hair,” 
“birth weight,” “birth length,” “infant weight,” 
and “postnatal growth.” The studies reviewed 
are summarized in Table 1 and Supplemental 
Material, Table S1 (http://dx.doi.org/10.1289/
ehp.1104494). 
Overall, studies on fetal mercury exposure 
and birth outcomes show mixed results [see 
Supplemental Material, Table S1 (http://
dx.doi.org/10.1289/ehp.1104494)]. A small 
study from Poland (n = 41) published in 
1986 found that infant, but not maternal, 
hair mercury was inversely associated with 
birth weight without consideration of fish or 
seafood consumption (Sikorski et al. 1986). 
In a more recent, larger cohort (n = 554) in 
Spain, Ramon et al. (2009) found that cord 
blood mercury was inversely related to birth 
weight. Newborns in the highest quartile for 
cord blood mercury weighed 143.7 g less [95% 
confidence interval (CI): –2251.8, –235.6] 
than those in the first quartile, after adjusting 
for fish consumption and other variables. 
These authors also observed a similar pattern 
for small-for-gestational-age newborns, 
although the results were not statistically 
significant. In a study examining cord blood 
mercury and maternal blood mercury both 
early (12–20 weeks) and late (28–42 weeks) in 
pregnancy in a South Korean cohort (n = 417), 
Lee et al. (2010) observed that birth weight 
was inversely related to all measures of mercury 
exposure, with the strongest magnitude of 
effect observed for cord blood. Of particular 
interest is that the associations were more 
pronounced among those with the glutathione 
S-transferase (GST) M1 (GSTM1) null 
genotype or both GSTM1 and GSTT1 null 
genotypes. MeHg excretion rates vary widely 
among individuals and involve glutathione 
conjugation by selenium-dependent GSTs 
(Custodio et al. 1994). Birth weight was 
unrelated to maternal hair mercury in a French 
cohort (n = 645) (Drouillet-Pinard et al. 
2010); maternal or cord blood mercury in a 
New York City cohort (n = 329) (Lederman 
et al. 2008); maternal blood, hair, or cord 
blood mercury in a small study (n = 53) from 
Vienna, Austria (Gundacker et al. 2010); 
cord blood mercury in a cohort study from 
Nunvik, Canada (n = 439) (Lucas et al. 2004); 
and cord tissue mercury in a large study in 
the United Kingdom (n = 1,040) (Daniels 
et al. 2007). The French, New York City, 
Austrian, and U.K. studies considered fish or 
seafood consumption, and the Canadian study 
accounted for PUFA in their analysis.
We found little to no evidence of effects 
of low-level mercury exposure on other 
studied anthropometric measures at birth. Of 
the five studies that evaluated birth length, 
none found any association (Drouillet-Pinard 
et al. 2010; Gundacker et al. 2010; Lederman 
et al. 2008; Ramon et al. 2009; Sikorski 
et al. 1986). Likewise, four studies recorded 
measurements of infant head circumference 
at birth, but none found clear associations 
with mercury exposure (Drouillet-Pinard et al. 
2010; Gundacker et al. 2010; Lederman et al. 
2008; Sikorski et al. 1986).
Gestational age was evaluated in five 
studies that met our criteria. No association 
was observed with gestational age in the 
Canadian study with cord blood mercury 
(Lucas et al. 2004), the U.K. cohort with 
cord tissue mercury (Daniels et al. 2007), the 
New York City cohort with maternal or cord 
blood mercury (Lederman et al. 2008), or the 
French cohort with maternal hair (Drouillet-
Pinard et al. 2010). In a study in Michigan 
(USA), however, Xue et al. (2007) found 
that women who delivered very preterm 
(< 35 weeks) were more likely to have had 
higher hair mercury levels (0.55–2.5 μg/g) 
than women who delivered at term (odds 
ratio = 3.0; 95% CI: 1.3, 6.7). 
Of further interest, cord blood mercury 
(Grandjean et al. 2003; Kim et al. 2011) 
and late-pregnancy maternal blood mercury 
(Kim et al. 2011) have been associated with 
impaired infant growth within the first 
2 years of life. One of these studies (Kim et al. 
2011), based on a South Korean birth cohort, 
met our inclusion criteria [Table 1; see also 
Supplemental Material, Table S1 (http://
dx.doi.org/10.1289/ehp.1104494)].
Health effects of low-level methylmercury
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Neurocognitive and Behavioral 
Outcomes
For neurodevelopmental outcomes, we 
searched databases using combinations of the 
following terms: “mercury,” “MeHg,” “blood,” 
“cord blood, “hair,” “low-dose,” “cognition,” 
“cognit ive function,” “ inte l l igence,” 
“IQ” (intelligence quotient), “memory,” 
“executive function,” “sensory function,” 
“visual evoked potentials,” “auditory evoked 
potentials,” “human behavior,” “behavior,” 
“neurobehavior,” “attention,” “impulsivity,” 
“impulse control,” “hyperactivity,” “motor 
skills,” and “fine motor performance.” The 
studies reviewed are summarized in Tables 1 
and 2 and Supplemental Material, Table S2 
(http://dx.doi.org/10.1289/ehp.1104494).
Prospective cohort studies have demon-
strated associations of prenatal mercury expo-
sure with neonatal motor function (Suzuki 
et al. 2010) and behavior (Gao et al. 2007). 
In descriptive analyses without adjustment for 
potential confounders, maternal pregnancy 
hair mercury ≥ 1 μg/g was associated with a 
smaller cerebellar volume among 137 full-
term Croatian newborns (Cace et al. 2011).
Among infants 6–24 months of age, 
prospective studies of low-level prenatal 
mercury exposure have had mixed results. 
Mercury (adjusted for pregnancy seafood 
intake) was associated with decrements in infant 
cognition including poorer visual recognition 
memory at 6 months of age in U.S. infants 
(Oken et al. 2005) and poorer performance 
on both Psychomotor Development Index 
(PDI) and Mental Development Index (MDI) 
components of the Bayley Scales of Infant 
Development at 12 months, as well as modest 
but nonsignificant declines at 24 months, 
among Polish infants in models unadjusted 
for fish consumption (Jedrychowski et al. 
2006, 2007). In contrast, among more highly 
exposed urban New York City children (e.g., 
geometric mean cord blood mercury = 4.4 μg/L 
vs. 0.9 μg/L in Polish infants), no significant 
prenatal mercury-associated decrements in 
12- and 24-month Bayley PDI and MDI 
scores were observed despite adjustment for 
multiple potential confounders including 
fish consumption (Lederman et al. 2008). 
Similarly, in a prospective U.K. study, cord 
tissue mercury was not associated with 
scores on the MacArthur Communicative 
Table 1. Summary of studies of low-level mercury exposure.
Outcome
No. of 
studies Sample size (range) Age (range) Exposure measures References
Birth outcomes and infant growth
Birth weight 8 41–645 — Cord blood, cord tissue, 
maternal hair
Daniels et al. 2007; Drouillet-Pinard et al. 2010; Gundacker et al. 
2010; Lederman et al. 2008; Lee et al. 2010; Lucas et al. 2004; 
Ramon et al. 2009; Sikorski et al.1986
Birth length 5 41–645 — Cord blood, maternal 
hair
Drouillet-Pinard et al. 2010; Gundacker et al. 2010; Lederman et al. 
2008; Ramon et al. 2009; Sikorski et al. 1986
Head circumference 4 41–645 — Cord blood, maternal 
hair
Drouillet-Pinard et al. 2010; Gundacker et al. 2010; Lederman et al. 
2008; Sikorski et al. 1986
Gestational age 5 329–1,024 — Cord blood, cord tissue, 
maternal hair
Daniels et al. 2007; Drouillet-Pinard et al. 2010; Lederman et al. 
2008; Lucas et al. 2004; Xue et al. 2007
Infant growth 1 921 24 months Cord blood Kim et al. 2011
Neurologic outcomes
Birth–2 years 10 53–1,054 Birth–26 months Cord blood, cord tissue, 
infant hair, maternal 
hair, maternal blood
Barbone et al. 2004; Cace et al. 2011; Cao et al. 2010; Daniels 
et al. 2004; Gao et al. 2007; Jedrychowski et al. 2006, 2007; 
Lederman et al. 2008; Oken et al. 2005; Suzuki et al. 2010
3–6 years 11 72–1,778 36 months– 
6 years
Cord blood, child hair, 
child blood, maternal 
hair, maternal blood
Cao et al. 2010; Després et al. 2005; Freire et al. 2010; Ha et al. 
2009; Jedrychowski et al. 2007; Lederman et al. 2008; Oken et al. 
2008; Plusquellec et al. 2010; Saint-Amour et al. 2006; Stewart 
et al. 2003; Surkan et al. 2009
7–14 years 6 100–1,778 7–14 years Cord blood, child hair, 
child blood
Boucher et al. 2010; Cao et al. 2010; Cheuk and Wong 2006; Ha 
et al. 2009; Surkan et al. 2009; Torrente et al. 2005
Adults 4 106–474 17 to ≥ 81 years Adult hair, adult blood Johansson et al. 2002; Philibert et al. 2008; Weil et al. 2005; 
Yokoo et al. 2003
Cardiovascular outcomes
8 Prospective cohort: 
1,014–1,871
16–75 years Hair, blood, toenail, 
urine mercury
Guallar et al. 2002; Mozaffarian et al. 2011; Rissanen et al. 2000; 
Salonen et al. 1995, 2000; Virtanen et al. 2005; Wennberg et al. 




Blood pressure 1 1,240 16–49 years Blood mercury Valera et al. 2009; Vupputuri et al. 2005
Immunologic outcomesa
1 Prospective cohort: 582 29–39 months Hair (child, maternal) Miyake et al. 2011
3 Cross-sectional: 
61–112
Newborns Blood (cord, maternal 
delivery)
Belles-Isles et al. 2002; Bilrha et al. 2003; Nyland et al. 2011a
1 Cross-sectional: 1,990 ≥ 20 years Blood Park and Kim 2011
See also Supplemental Material, Table S1–S4 (http://dx.doi.org/10.1289/ehp.1104494). 
aStudies published since the NRC report (NRC 2000). 
Table 2. Summary of findings on MeHg and neurocognitive and behavioral outcomes.
Age at assessment
Birth–2 years 3–6 years 7–14 years Adults
Inconsistent effects: no effect; 
increased risk associated with 
prenatal or postnatal mercury
Adverse effects if adjusted for fish intake: multiple 
associations with prenatal mercury (psychomotor 
function, memory, verbal skills cognition, etc.); 
inconsistent effects with concurrent mercury
Inconsistent effects: protective; no effect; 
increased risk (e.g., electrophysiologic 
testing) with prenatal or postnatal mercury
Inconsistent effects: no effect or adverse 
neuropsychological test performance with 
current mercury
See also Supplemental Material, Table S2 (http://dx.doi.org/10.1289/ehp.1104494). 
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Development Inventory at 15 months of age 
or the Denver Developmental Screening Test 
at 18 months of age despite adjustment for 
multiple potential confounders including fish 
consumption (Daniels et al. 2004). However, 
increased measurement error of mercury in 
cord tissue (compared with hair or blood) may 
have contributed to null findings (Grandjean 
and Budtz-Jørgensen 2007; Grandjean and 
Herz 2011).
In preschool-age children, prenatal mer-
cury exposure has been consistently associated 
with adverse subsequent neurodevelopment 
in analyses accounting for maternal preg-
nancy fish consumption (Freire et al. 2010; 
Lederman et al. 2008; Oken et al. 2008). For 
example, among New York City infants in 
whom prenatal mercury was not associated 
with significant Bayley decrements at 12 and 
24 months of age, significant PDI (but not 
MDI) declines were seen at 36 months, and 
a 3.6-point decline in IQ (per log increase 
in cord blood mercury) was seen at 4 years 
(Lederman et al. 2008). Prenatal mercury 
exposures have been associated with other 
cognitive and psychomotor measures in this 
age group, such as lower scores on tests of 
vocabulary (Peabody Picture Vocabulary 
Test) and visual-motor ability (Wide Range 
Assessment of Visual Motor Abilities) at 
3 years of age (Oken et al. 2008) and poorer 
general cognition, memory, and verbal skills 
(McCarthy Scales of Children’s Abilities) at 
4 years of age (Freire et al. 2010).
However, without adjustment for fish 
intake, prenatal mercury exposures have been 
associated with inconsistent (Stewart et al. 
2003) or even beneficial (Jedrychowski et al. 
2007) findings in this age group (Stewart et al. 
2003). For example, among Polish infants 
in whom prenatal mercury was associated 
with decrements in Bayley PDI and MDI at 
12 months of age (and nonsignificant decre-
ments at 24 months), mercury was associ-
ated with nonsignificant increases in Bayley 
scores at 36 months in analyses unadjusted for 
fish intake (Jedrychowski et al. 2006, 2007). 
Among 3-year-old U.S. children born to moth-
ers consuming MeHg-contaminated Great 
Lakes fish, prenatal mercury was associated 
with poorer general cognition on the McCarthy 
Scales only among children with high prenatal 
exposure to polychlorinated biphenyls (PCBs). 
Stewart et al. (2003) observed no mercury- 
related effects on the McCarthy Scales in fol-
low up at 4.5 years of age, but their analyses 
were not adjusted for fish consumption. 
Studies of postnatal mercury exposures in 
young children have produced mixed results. 
In a small sample (n = 53) of 26-month-old 
Italian children, higher 3-month postpartum 
infant or maternal hair mercury levels (e.g., 
< 1 μg/g vs. ≥ 1 μg/g) were marginally associ-
ated with increased risk of expected or delayed 
(vs. advanced) fine motor skill on the Denver 
Developmental Screening Test in analyses 
unadjusted for fish consumption (Barbone 
et al. 2004). Among 24-month-old U.S. par-
ticipants in a randomized trial of chelation for 
lead poisoning, current mercury concentra-
tion was associated with better (nonsignifi-
cant) Bayley MDI scores (Cao et al. 2010). 
In follow-up of these children at 5 and 7 years 
of age, increased blood mercury at baseline 
(age 2 years) was associated with no signifi-
cant differences in IQ or behavior; however, 
point estimates of effect were all positive (i.e., 
improved with increasing mercury) (Cao et al. 
2010). No information about fish consump-
tion was available in that study.
Even with adjustment for fish consumption 
or related nutritional measures, associations of 
postnatal mercury exposure with neurodevel-
opment have been inconsistent. A prospective 
study of Inuit children in Nunavik, Canada 
(the high end of the low-exposure range) is of 
interest given its simultaneous assessment of 
prenatal and postnatal (concurrent) mercury 
levels and its inclusion of measures of other 
neurotoxicants (PCBs, organochlorine pesti-
cides, and lead), as well as potential nutritional 
confounders (selenium and omega-3 PUFA) 
(Després et al. 2005; Plusquellec et al. 2010; 
Saint-Amour et al. 2006). In a study using 
the Infant Behavioral Rating Scale from the 
Bayley Scales of Infant Development-II and 
scoring of video-recorded behaviors, neither 
prenatal nor childhood mercury were related 
to behavior at 4–6 years of age (Plusquellec 
et al. 2010). However, in tests of gross and 
fine motor skill, current, but not prenatal, 
mercury was associated with increased action 
tremor amplitude at 4–6 years of age (Després 
et al. 2005). Finally, at ages 5–6 years, prenatal 
mercury was associated with longer latencies in 
visual evoked potentials (VEPs), whereas con-
current mercury was associated with shorter 
VEP latencies (Saint-Amour et al. 2006), an 
indicator of visual information–processing effi-
ciency. The most recent published follow-up 
of this population assessed performance on 
auditory event-related potentials (ERPs) at 
ages 10–13 years. Cord blood mercury was 
associated with both adverse and potentially 
beneficial effects on early auditory information 
processing, with increased reaction time and 
increased latency but fewer false alarms (i.e., 
false-positive errors) and greater amplitude of 
response on the auditory ERP task (Boucher 
et al. 2010). Of note, concurrent blood mer-
cury (median, 2.8 μg/L) was not associated 
with auditory ERP performance.
To date, most published studies among 
older children of school age are cross-sectional, 
with mercury biomarkers indicating postnatal 
exposure levels. With few exceptions (Boucher 
et al. 2010), studies in this age group do not 
demonstrate adverse associations of concurrent 
mercury exposure with a range of cognitive 
and neurobehavioral measures, and most lack 
information about potential confounding 
by fish consumption. For example, among 
355 participants 6–10 years of age in a 
randomized trial of mercury amalgam versus 
composite restorations for dental carries, 
Surkan et al. (2009) observed no significant 
linear relationship of baseline mercury 
obtained before amalgam exposure across 
18 psychometric tests, including measures 
of IQ, achievement, memory, executive 
function, and visual-motor and fine motor 
ability. Null results remained after adjustment 
for multiple potential confounders, including 
fish consumption. However, the authors 
identified nonlinearities in dose response 
with suggestive evidence of improved math 
reasoning and visual-motor skills at hair 
mercury < 0.5 μg/g but decrements on the 
same tests at higher levels (0.5 μg/g ≤ hair 
mercury ≤ 1.0 μg/g) and insufficient data at 
hair mercury > 1.0 μg/g. In a school survey 
of 1,778 South Korean 6- to 10-year-old 
children, parental report of attention deficit 
hyperactivity disorder (ADHD) symptoms 
was unrelated to concurrent mercury (Ha 
et al. 2009); information about fish intake 
was not included in the study. Conversely, in 
a case–control study of ADHD among 111 
7- to 8-year-old children in Hong Kong, 
China, higher blood mercury was associated 
with increased odds of ADHD diagnosis 
(Cheuk and Wong 2006). However, that study 
had a number of limitations, including lack of 
comparability of cases and controls on ADHD 
risk factors and lack of information on fish 
intake. Finally, in a cross-sectional assessment 
of 100 Spanish children 12–14 years of age, 
concurrent hair mercury level was correlated 
with better visuospatial skill after adjustment 
for age and socioeconomic status (Torrente 
et al. 2005). These authors postulated that 
findings were consequent to confounding by 
fish consumption, which was not assessed. 
Only a few cross-sectional studies of neu-
rologic effects of low-level mercury exposure 
have been carried out in adults. Although 
Yokoo et al. (2003) did not include fish intake 
in assessments, higher hair mercury levels were 
associated with decrements in fine motor speed 
and dexterity, as well as memory and response 
inhibition, among 129 adults (mean age, 
35 years; range, 17–81 years) from Brazilian 
fishing communities. Conversely among a ran-
dom subset (n = 474) of older adults (ages 
50–70 years) in the Baltimore Memory Study 
(Baltimore, MD), blood mercury was associ-
ated with improved manual dexterity (finger 
tapping) but poorer visual memory in analyses 
considering fish intake (Weil et al. 2005). In 
a study of 106 elderly Swedish adults (mean 
age, 87 years) by Johansson et al. (2002), 
blood mercury was not associated with general 
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cognitive status, including memory, assessed 
on the Mini Mental State Examination; how-
ever, there was no assessment for confounding. 
Finally, among lake-fish eaters in Quebec, 
Canada (mean age, 47–50 years), higher 
hair mercury was associated with increased 
self-reported neuropsychiatric symptoms of 
depression, anxiety, and obsessive–compulsive 
behavior (Philibert et al. 2008). However, 
this association was seen only in women, and 
symptom reporting was not related to blood 
mercury levels or serum PUFA levels.
Cardiovascular Outcomes
For literature searches for MeHg and 
cardiovascular outcomes, we used the key 
words “mercury” or “methylmercury,” 
“ ca rd iova scu l a r ”  o r  “ co ronary , ”  o r 
“hypertension.” References cited in articles 
were also identified. The studies reviewed 
are summarized in Tables 1 and 3 and in 
Supplemental Material, Table S3 (http://
dx.doi.org/10.1289/ehp.1104494). 
Although the developing brain is 
considered the critical target organ of MeHg 
toxicity for children, the cardiovascular 
system may be most sensitive for adults. In 
the studies we reviewed, the cardiovascular 
outcomes included myocardial infarction, 
blood pressure, heart rate variability, and 
atherosclerosis. Among the studies that met 
our definition of a low-level exposure, the 
studies carried out in Finland were the first 
to assess the association between MeHg 
and cardiovascular disease (CVD) (e.g., 
Salonen et al. 1995). A > 2-fold risk of 
acute myocardial infarction and mortality 
from coronary heart disease and CVD 
was associated with elevated hair mercury 
(> 2 μg/g). Inclusion of fatty acids had 
no appreciable effect on the relative risk 
estimates. As recently reviewed by Roman 
et al. (2011), subsequent studies have 
corroborated a potential link between MeHg 
and acute myocardial infarction. Mercury 
was associated with accelerated progression 
of carotid atherosclerosis, as determined 
by intima-media thickness (Salonen et al. 
2000). The association remained significant 
after adjusting for fatty acids and selenium. 
Rissanen et al. (2000) reported that fish oil–
derived fatty acids reduced the risk of acute 
coronary events. In a later study of Finnish 
men, Virtanen et al. (2005) reported that 
increased mercury exposure was associated 
with increased risk of acute coronary events 
and cardiovascular mortality, with adjustment 
for selenium and fatty acids. These two studies 
(Rissanen et al. 2000; Virtanen et al. 2005) 
concluded that mercury may attenuate the 
protective effects of fish on cardiovascular 
health. A large multicenter study from Europe 
showed an increased risk of CVD associated 
with toenail mercury concentrations after 
controlling for DHA (docosahexaenoic acid) 
(Guallar et al. 2002), whereas no association 
was found in the U.S. Health Professionals 
Study, with adjustment for DHA plus 
eicosapentaenoic acid (Yoshizawa et al. 2002). 
In a nested case–control study combining the 
U.S. male health professionals and the female 
registered nurses cohorts (Nurses’ Health 
Study), Mozaffarian et al. (2011) found 
no adverse effects of mercury exposure on 
coronary heart disease, stroke, or total CVD. 
Findings were similar in additional analyses 
adjusted for DHA, eicosapentaenoic acid, and 
selenium. In a Swedish nested case–control 
study with low exposure, Wennberg et al. 
(2011) found no association between the 
risk of myocardial infarction and mercury 
concentration in erythrocytes with adjustment 
for DHA plus eicosapentaenoic acid. Another 
nested case–control study reported an inverse 
association between myocardial infarction 
and erythrocyte mercury (Hallgren et al. 
2001); however, that study did not meet our 
definition of low-level exposure. 
Several studies have found an association 
between increased mercury and increased 
blood pressure in adults, although only two 
met our low-dose exposure definition: Valera 
et al. (2009) adjusted for fish nutrients (DHA, 
eicosapentaenoic acid, and selenium), whereas 
Vupputuri et al. (2005) controlled for fish 
intake. In cross-sectional population data 
from the U.S. National Health and Nutrition 
Examination Survey (NHANES), associations 
were seen only among individuals who did not 
consume fish (Vupputuri et al. 2005). Among 
children more heavily exposed than criteria 
used in our review, an association between pre-
natal mercury exposure and childhood blood 
pressure has been observed in some (Sorensen 
et al. 1999; Thurston et al. 2007) but not all 
(Grandjean et al. 2004) studies; however, 
information on nutrients and fish consump-
tion was not available in these studies. 
MeHg may induce oxidative stress, an 
early biological response that can produce 
cell damage in several organs or systems 
including the cardiovascular system (Grotto 
et al. 2009). Experimental models suggest 
that oxidative stress plays an important role 
in the toxicodynamics of mercury (Grotto 
et al. 2010). A few recent studies have 
examined associations between mercury 
exposure and oxidative stress or antioxidant 
defense in populations exposed through fish 
consumption, although the findings have been 
inconclusive (Bélanger et al. 2008; Grotto 
et al. 2010; Pinheiro et al. 2008). These 
studies, however, have reported mercury 
concentrations that exceeded our definition 
of low-level exposure. Except for Grotto et al. 
(2010), information on fish intake was not 
available.
Immunologic Outcomes
In 2000, the NRC summarized the available 
literature on immunotoxicity of mercury (NRC 
2000). Study results showed that occupational 
exposure to inorganic forms of mercury was 
associated with alterations in B lymphocytes, 
T-helper cells, T-suppressor cells, and T-cell 
proliferative responses (Moszczynski et al. 
1995; Queiroz and Dantas 1997a, 1997b). The 
NRC report also cited several animal studies 
involving exposure to MeHg and indicators 
of immunotoxicity (e.g., Ilbäck et al. 1991). 
The NRC (2000) concluded that the immune 
system appears to be sensitive to mercury and 
noted that toxicologic studies have observed 
effects on immune-cell ratios, cellular response, 
and the developing immune system. However, 
at the time of the NRC report, there were no 
published epidemiologic studies of MeHg and 
immune function.
For immunologic outcomes, we focused 
on studies published since the comprehensive 
NRC report (i.e., post-1999), most of which 
have hair or blood mercury levels well in 
excess of the low-level range of our review 
or focus on elemental mercury exposure. 
For example, evidence of mercury-associated 
immunotoxicity,  including increased 
frequency of antinuclear autoantibodies, 
changes in serum cytokine levels, and risk of 
malaria infection, has been observed in studies 
of heavily exposed Amazonian fish eaters and 
gold-mining populations (Alves et al. 2006; 
Crompton et al. 2002; Gardner et al. 2010; 
Nyland et al. 2011b). However, urinary 
mercury levels reflective of elemental mercury 
exposure from amalgam dental restorations 
Table 3. Summary of findings on MeHg and cardiovascular outcomes.
Study location or group Outcomes
Positive associations
Finland Hair mercury positively related to acute myocardial 
infarction and CHD and CVD mortality.
Europe and Israel Toenail mercury positively associated with 
myocardial infarction
No associations
Health Professionals Study and Nurses’ Health Study Toenail mercury unrelated to incident CVD
National Health and Nutrition Examination Survey (NHANES) Blood mercury not associated with blood pressure
Sweden Erythrocyte mercury not associated with risk of 
myocardial infarction
See also Supplemental Material, Table S3 (http://dx.doi.org/10.1289/ehp.1104494). 
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in children has not been associated with 
immunotoxicity (Shenker et al. 2008).
Table 1 and Supplemental Material, 
Table S4 (http://dx.doi.org/10.1289/
ehp.1104494) summarize the studies with 
low-level MeHg exposures that we reviewed. 
Nyland et al. (2011a) reported significant cor-
relations of both maternal and cord blood mer-
cury (respective geometric means of 6.9 μg/L 
and 9.6 μg/L) with increases in cord blood 
total IgG among 61 mother–infant pairs in 
the Brazilian Amazon. In that study, which did 
not adjust for fish consumption, blood mer-
cury was not associated with either maternal 
or fetal levels of antinuclear autoantibodies or 
serum cytokines. In a recent population-based 
survey of Korean adults (n = 1,990), higher 
blood mercury (geometric mean, 4.3 μg/L) 
was associated with increased risk of self-re-
ported atopic dermatitis in multivariable analy-
ses adjusted for fish consumption (Park and 
Kim 2011). As part of the Osaka Maternal 
and Child Health Study, Miyake et al. (2011) 
evaluated 582 mother–child pairs in Japan for 
mercury exposure, using both maternal hair 
(median, 1.5 μg/g) and hair collected from 
their offspring 29–39 months of age (median, 
1.4 μg/g). After adjustment for multiple poten-
tial confounders, including maternal fish con-
sumption during pregnancy and child fish 
consumption, the authors detected no associa-
tion between either maternal or child hair mer-
cury and risk of childhood wheeze or eczema. 
Belles-Isles et al. (2002) compared 
Canadian infants (n = 48) born to a popu-
lation of subsistence fishers with a reference 
population (n = 60 infants) from coastal towns 
(geometric mean cord blood mercury of 1.8 
and 0.9 μg/L, respectively). Cord blood mer-
cury was inversely correlated with the propor-
tion of naive helper T cells and plasma IgM 
levels in cord blood but unrelated to multiple 
other measures of T-, B-, and natural killer cell 
proportions and function. Of note, these anal-
yses were not adjusted for potential confound-
ing, including the substantial organochlorine 
exposures and greater prevalence of smoking 
during pregnancy among subsistence fishers 
compared with referent mothers. Bilrha et al. 
(2003) studied children born to subsistence 
fishers (n = 47) and town residents (n = 65) 
from the same Canadian region to expand 
on assessments in Belles-Isles et al. (2002). In 
correlational analyses (unadjusted for poten-
tial confounders), the authors observed no 
relationship between cord blood mercury and 
cord blood lymphocyte activation markers or 
cytokine secretion.
Summary
Birth outcomes and infant growth. To date, 
relatively few studies have evaluated the effects 
of MeHg on fetal growth and gestation. An 
advantage of studying birth outcomes is the 
limited time window of exposure. Lee et al. 
(2010) measured maternal mercury levels at 
multiple time points during pregnancy, with 
similar results. The largest number of studies 
assessed birth weight, but the differing matrices 
used to measure exposure make comparison 
between studies challenging. Several studies 
evaluated cord blood mercury concentrations 
but employed differing statistical approaches 
(e.g., analysis of categorical vs. continuous 
data). Of interest, two studies that provided a 
statistical estimate adjusted for fish intake both 
found evidence of reduced birth weight in 
relation to cord blood mercury concentrations 
(Lee et al. 2010; Ramon et al. 2009), whereas 
another study that did not adjust for fish 
and seafood intake (but did examine plasma 
PUFA) did not observe such associations 
(Lucas et al. 2004). Of the studies that 
evaluated associations of cord blood mercury 
levels with gestational age, one provided 
a statistical estimate of an association with 
prematurity (Xue et al. 2007); another study 
did not find a relation with gestational age but 
did not specifically evaluate preterm deliveries 
(Lucas et al. 2004). Size for gestational age 
is of interest, but only one study to date has 
reported on this outcome (Ramon et al. 
2009); although results were suggestive of a 
mercury effect, they lacked statistical power. 
Thus, the potential impact of low-level MeHg 
on fetal growth is uncertain, although there 
is suggestive evidence of an effect. Finally, in 
addition to possible influences of low-level 
in utero mercury exposure on fetal growth, 
recent data raise the possibility of effects on 
postnatal growth (Kim et al. 2011).
Neurocognitive and behavioral outcomes. 
The literature on low-level mercury and neu-
rodevelopment underscores the importance 
of exposure timing, precision of the exposure 
assessment, confounding, age at assessment, 
the specific neurobehavioral outcome, sex dif-
ferences, and dose–response modeling in deter-
mining the observed results. For example, in 
children, prenatal exposure may be more del-
eterious than postnatal exposure for most, but 
likely not all, neurodevelopmental measures 
(Myers et al. 2009; Saint-Amour et al. 2006). 
With some exceptions (Daniels et al. 2004; 
Plusquellec et al. 2010), studies in which null, 
or potentially beneficial, associations with mer-
cury were seen typically lacked measures of 
fish consumption or related nutrients, such as 
PUFA, which could confound findings and 
account for null or apparently neuroprotec-
tive mercury effects (Cao et al. 2010; Ha et al. 
2009; Johansson et al. 2002; Torrente et al. 
2005). An example of the complexity of this 
literature is the variability among associations 
of low-level prenatal mercury with performance 
on the Bayley Scales of Infant Development 
between 12 and 36 months of age. Prenatal 
mercury effects were seen only at 12 months 
of age in some populations (Jedrychowski et al. 
2006, 2007) or only at 36 months of age in 
others (Lederman et al. 2008). In contrast, 
postnatal exposure has been associated with 
improved Bayley performance at 24 months of 
age (Cao et al. 2010) but without adjustment 
for fish consumption. In the low-level expo-
sure literature, differences in exposure and con-
founding (including diet), as well as differences 
in neurodevelopmental test sensitivity, may 
account for some apparent inconsistencies.
Findings in children and adults are 
difficult to compare, at least in part, because 
of differences in testing protocols. In 
addition, among populations with chronic 
mercury exposure, associations with mercury 
measured in later life may reflect the long-
term developmental consequences of early-
life exposure. However, where there is general 
overlap in assessments, findings are surprisingly 
concordant. For example, concurrent blood 
mercury was associated with increased action 
tremor amplitude in 4- to 6-year-old Inuit 
children (Després et al. 2005) and poorer fine 
motor speed and dexterity in Brazilian adults 
(Yokoo et al. 2003). Regardless of age, certain 
domains of function may be more sensitive 
to mercury toxicities, including memory 
(Freire et al. 2010; Oken et al. 2005; Weil 
et al. 2005), verbal or language skills (Freire 
et al. 2010; Lederman et al. 2008; Oken et al. 
2008), and visual-motor functions (Oken et al. 
2008; Surkan et al. 2009). In contrast, except 
in a case–control analysis of ADHD (Cheuk 
and Wong 2006), adverse behaviors were not 
associated with mercury exposure in children 
(Cao et al. 2010; Ha et al. 2009; Plusquellec 
et al. 2010).
Cardiovascular outcomes. No clear pat-
tern has been observed among the limited 
number of studies that assessed the association 
between low-level mercury and cardiovascular 
function. The evidence, however, suggests that 
adverse cardiovascular effects can occur at very 
low levels of mercury exposure. For example, 
men who had a hair mercury concentration 
of ≥ 2 μg/g had a 2-fold increased risk of suf-
fering an acute myocardial infarction or dying 
from coronary heart disease or CVD com-
pared with less-exposed men (Salonen et al. 
1995). Although essential fatty acids from fish 
may reduce the risk of acute coronary events, 
mercury in fish could attenuate this beneficial 
effect (Rissanen et al. 2000). Eastern Finnish 
men in the lowest two tertiles of hair mer-
cury concentration (0–2 μg/g) who also were 
in the highest quintile of serum fatty acid 
levels had a 67% reduced risk of acute coro-
nary events compared with men in the high-
est tertile of hair mercury who were in the 
lowest quintile of serum fatty acids. In that 
cohort, the increased risk seemed to occur at 
hair mercury concentrations > 2 μg/g, that 
is, only 2 times the level corresponding to 
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daily mercury intake at the U.S. EPA refer-
ence dose (a level estimated to be without sig-
nificant risk of adverse effects over a lifetime) 
(Salonen et al. 1995). In contrast, in a large 
multicenter cohort in Europe, an increased 
risk of myocardial infarction was found in 
participants with toenail mercury concentra-
tions of 0.36 μg/g, approximating an even 
lower hair mercury level of < 1 μg/g (Guallar 
et al. 2002; Ohno et al. 2007). 
Immunologic outcomes. Relatively high 
exposure to elemental mercury has been linked 
to a range of immunologic outcomes (includ-
ing markers of autoimmunity) in epidemio-
logic studies, but evidence of immunotoxicity 
of low-level MeHg is inconclusive in the lim-
ited literature available to date. It is difficult, 
however, to make any definitive statements as 
to which forms of mercury are likely to affect 
which immune components. Much of the 
available epidemiologic literature is limited by 
small sample sizes, incomplete adjustment for 
potential confounders, and lack of consistency 
across exposure media (e.g., only hair in some 
populations, only urine in others), which have 
impeded making the comparisons across studies 
that are necessary for refined hypothesis gen-
eration and testing. Dialogue among mercury 
researchers is also needed to identify optimal 
measures of potential immune impairment.
Priorities for Future Studies
Despite evidence of possible differences in 
mercury toxicities between the sexes (Marsh 
1994), most studies did not report assessing 
such differences. Only two of the reviewed 
studies on neurologic outcomes reported sex 
differences in mercury effects: Only male 
infants had mercury-associated decrements 
in behavior (Gao et al. 2007), and only 
adult women reported increased psychiatric 
symptoms associated with mercury (Philibert 
et al. 2008). In addition to sex-specific effects, 
other host factors could influence susceptibility 
to MeHg effects. Although research on these 
factors is scarce, a recent Korean study of fetal 
growth found evidence of genetic susceptibility, 
with genetic variation in GSTM1 and GSTT1 
affecting risk (Lee et al. 2010). Future studies 
should emphasize the use of the most precise 
exposure indicators in sensitivity analyses 
to model the impact of likely imprecision 
(Budtz-Jørgensen et al. 2003). Similarly, 
future studies should use outcome measures 
for which there are mechanistic or other 
a priori bases for assuming mercury sensitivity. 
The potential for nonlinear dose–response 
relationships (e.g., a threshold dose response) 
needs to be considered consistently. Because 
MeHg originates from fish and seafood, 
which also contain nutrients that may be 
beneficial to health (including birth outcomes, 
neurodevelopment, cardiovascular health, and 
immune function), proper adjustment for 
potential negative confounding by nutrition is 
crucial in any future study.
Summary of Findings
The possibility that MeHg at low expo-•	
sure levels might affect fetal growth among 
susceptible subgroups and infant growth 
requires further investigation. 
There is evidence that low levels of prenatal •	
MeHg exposure may cause early childhood 
neurocognitive effects. The possibility of 
nonlinear effects, as well as possible differ-
ential effects by sex, should be evaluated for 
older children and adults. 
There are no clear patterns across popula-•	
tions or for specific study end points for 
cardiovascular effects of low-level MeHg 
exposure. Future studies targeted at mecha-
nisms of effects may be informative (e.g., 
effects on heart rate variability). In addition, 
sexual dimorphism and nonlinearity should 
be considered.
Although there are some indications of •	
MeHg-associated immune effects, epide-
miologic studies addressing this question are 
scarce, have small sample sizes, and include 
limited assessment of important potential 
confounders. Thus, we cannot draw any 
conclusions at this time. 
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